Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to 0.42.

  • Legend Biotech's Asset Utilization Ratio rose 70.25% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 70.25%. This contributed to the annual value of 0.36 for FY2024, which is 98.77% up from last year.
  • Latest data reveals that Legend Biotech reported Asset Utilization Ratio of 0.42 as of Q3 2025, which was up 14.98% from 0.37 recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Asset Utilization Ratio ranged from a high of 0.42 in Q3 2025 and a low of 0.08 during Q1 2023.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.21 (2024), whereas its average is 0.22.
  • Per our database at Business Quant, Legend Biotech's Asset Utilization Ratio slumped by 99.85% in 2021 and then spiked by 132.02% in 2024.
  • Quarterly analysis of 5 years shows Legend Biotech's Asset Utilization Ratio stood at 0.09 in 2021, then plummeted by 45.85% to 0.12 in 2022, then plummeted by 30.25% to 0.11 in 2023, then spiked by 132.02% to 0.26 in 2024, then spiked by 70.25% to 0.42 in 2025.
  • Its Asset Utilization Ratio stands at 0.42 for Q3 2025, versus 0.37 for Q2 2025 and 0.33 for Q1 2025.